Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.639%)
Open: 62.00
High: 62.00
Low: 61.50
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

11 Jun 2020 13:21

RNS Number : 7070P
Tissue Regenix Group PLC
11 June 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Tissue Regenix Group Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Jupiter Asset Management Limited

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

Northern Trust (Custody)

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

10th June 2020

6. Date on which issuer notified (DD/MM/YYYY):

11th June 2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

Below 5 %

0%

Below 5 %

7,031,597,534

Position of previous notification (if

applicable)

5.93%

N/A

5.93%

1,161,068,755

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

GB00B5SGVL29

N/A

Below 5 %

N/A

Below 5 %

SUBTOTAL 8. A

Below 5 %

Below 5 %

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

N/A

 

N/A

 

N/A

 

N/A

 

N/A

SUBTOTAL 8. B 1

 

N/A

 

N/A

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

N/A

 

N/A

 

N/A

 

N/A

 

N/A

 

N/A

SUBTOTAL 8.B.2

N/A

N/A

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Jupiter Fund Management Plc

Jupiter Fund Management Group Limited

Jupiter Asset Management Group Limited

Knightsbridge Asset Management Limited

Jupiter Investment Management Group Limited

Jupiter Asset Management Limited

Below 5 %

0%

Below 5 %

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Contact : Jon Watson

 

Telephone Number : 0203 817 1672

 

Place of completion

London, UK

Date of completion

11th June 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEAAKFFFDEEFA
Date   Source Headline
11th Jun 202011:20 amRNSHoldings in Company
11th Jun 202011:05 amRNSSecond Price Monitoring Extn
11th Jun 202011:00 amRNSPrice Monitoring Extension
10th Jun 20204:53 pmRNSHoldings in Company
10th Jun 20204:51 pmRNSHoldings in Company
10th Jun 20204:49 pmRNSHoldings in Company
10th Jun 20204:35 pmRNSHoldings in Company
9th Jun 20201:10 pmRNSResult of General Meeting and Total Voting Rights
5th Jun 20209:15 amRNSDirector subscriptions/PDMR dealing
5th Jun 20207:00 amRNSAnnual results for the year ended 31 December 2019
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:35 pmRNSPrice Monitoring Extension
3rd Jun 20202:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20202:00 pmRNSPrice Monitoring Extension
1st Jun 20209:05 amRNSSecond Price Monitoring Extn
1st Jun 20209:00 amRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSCE Mark awarded for OrthoPure XT
29th May 202011:05 amRNSSecond Price Monitoring Extn
29th May 202011:00 amRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:36 pmRNSPrice Monitoring Extension
26th May 20207:00 amRNSPublication of circular and notice of GM
22nd May 20202:00 pmRNSPrice Monitoring Extension
22nd May 202011:05 amRNSSecond Price Monitoring Extn
22nd May 202011:00 amRNSPrice Monitoring Extension
22nd May 20207:00 amRNSConfirmation of successful fundraising
21st May 20204:47 pmRNSPrimaryBid.com Offer
21st May 20204:43 pmRNSProposed Equity Fundraise
11th May 20207:00 amRNSNew collaboration with leading healthcare company
20th Apr 20207:00 amRNSAdditional US government-backed loan secured
15th Apr 20207:00 amRNSUS Government backed loan extends cash runway
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSUpdate in relation to working capital position
20th Mar 20207:00 amRNSDirectorate Change
6th Feb 20207:15 amEQSHardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
4th Feb 202011:47 amRNSResolution of Cyber Security Incident
28th Jan 202010:02 amRNSNotice of cyber security incident
22nd Jan 20207:00 amRNSTrading Update
14th Jan 20204:40 pmRNSSecond Price Monitoring Extn
14th Jan 20204:35 pmRNSPrice Monitoring Extension
21st Nov 20194:35 pmRNSPrice Monitoring Extension
18th Nov 20194:03 pmRNSDirectorate Change
14th Nov 20194:00 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSUpdated loan facility agreement with MidCap
13th Nov 20193:35 pmRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSUpdate in relation to loan facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.